Performance Measurement Network

Question: Consideration of PRADAXA as anticoagulation therapy for patients with atrial fibrillation

This is follow up to a prior question: "";.

Until Pradaxa is added to the list of approved anticoagulants, can we answer yes to anticoagulation therapy prescribed at discharge or must there be specific documentation that PRADAXA was the reason for not prescribing other anticoagulation therapy,e.g.Coumadin?


If PRADAXA (dabigatran) is prescribed at discharge, select 'Yes' for Anticoagulation Therapy Prescribed at Discharge. Treat PRADAXA the same as warfarin.

Question Details
Focus area(s): Chart Abstracted Measure Specifications – Clinical
Related documents: STK-03, STK 3 Atrial Fibrillation and anticoagulation, Appendix: Medication tables

Copyright © by the contributing authors. All material on this collaboration platform is the property of the contributing authors.
Ideas, requests, problems regarding Performance Measurement Network? Send feedback
This website is using cookies. More info. That's Fine